top of page
  • Jonathan Poyer

Biotech M&A Happenings - Roche Acquires Telavant for $7.1B; Bristol Acquires Mirati for $4.8B





Week Ending October 20th, 2023


  • Biotech: 5 Transactions (1 IPO, 3 Follow-Ons, and 1 PIPE) totaling just under $1 Billion

  • Med Tech: No Current Week Transactions

2023 YTD


  • 145Biotech transactions totaling just under $22 Billion v. 2022: 125 Biotech transactions totaling just under $16 Billion

  • 16 Med Tech transactions totaling just over $1 Billion v. 2022: 10 Med Tech transactions just under $900 Million


Private Transactions:


  • Biotech: 196Transactions / 57 European Transactions

  • Med Tech: 108 US Transactions / 35 European Transactions


October Major Transactions:

  • Roche aqcuired Telavant - $7.1B

  • Bristol Myers Squibb aquired Mirati Therapeutics - $4.8B; $58/Share

  • AbbVie acquired Mitokinin - $110M

  • Kyowa Kirin acquired Orchard Therapeutics - $387M; $16/Share

  • Eli Lilly acquired Point Biopharma - $1.4B; $12.50/Share

September Major Transactions:


  • Alfasigma acquired Intercept Pharmaceuticals - $794M; $19/Share


August Major Transactions:


  • Otsuka Pharmaceutical acquired Mindset Pharma - $59M; $0.75/Share

  • Harmony Biosciences acquired Zynerba Pharmaceuticals - $60M; $1.11/Share

  • Regeneron acquired Decibel Therapeutics - $107M; $4/Share

7 views0 comments

Comments


bottom of page